AUTHORS: Thompson, Sara J. MSc et al Anesthesia & Analgesia: August 2017 – Volume 125 – Issue 2 – p 434–441 BACKGROUND: Malignant hyperthermia (MH), a pharmacogenetic disorder of skeletal muscle, presents with a potentially lethal hypermetabolic reaction to certain anesthetics. However, some MH-susceptible patients experience muscle weakness, fatigue, and exercise intolerance in the absence of anesthetic […]
Read MorePatients with the rare disease erythromelalgia who responded favorably to corticosteroid treatment have been found to have specific characteristics: They reached maximum pain intensity within 21 days of onset, described a clear trigger to their disease (typically surgery or trauma) and were treated more promptly with steroids after diagnosis. The study’s principal investigator, Gabriel Pagani-Estévez, […]
Read MoreAUTHORS: As-Sanie, Sawsan MD, MPH et al Obstetrics & Gynecology: December 2017 – Volume 130 – Issue 6 – p 1261–1268 OBJECTIVE: To quantify physician prescribing patterns and patient opioid use in the 2 weeks after hysterectomy at an academic institution and to determine whether patient factors predict postsurgical opioid use and pain recovery. METHODS: We conducted a […]
Read MoreAuthor: Shale Imeson, MD The saying “May you live in interesting times,” is perhaps especially meaningful for those of us navigating the tumultuous world of today’s health care marketplace. As reimbursement shifts toward value-based payments, the health care industry struggles to find ways to meet new demands for efficiency, including improved outcomes and lower costs. […]
Read MoreTranscutaneous CO2 (TcCO2) more accurately reflects blood levels of the gas than end-tidal CO2(EtCO2) in infants, according to investigators at Stony Brook University, New York. Kseniya Khmara, MD, a clinical anesthesia resident at Stony Brook University School of Medicine, explained that the inaccuracies often observed using EtCO2 because of the small tidal volumes inhaled by neonates motivated […]
Read More